Skip to main content

Advertisement

Log in

Preoperative Prediction of Sarcopenia in Patients Scheduled for Gastric and Colorectal Cancer Surgery

  • Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

Sarcopenia negatively impacts surgical outcomes in gastrointestinal cancer patients, yet practical preoperative screening tools are lacking. The CRP/ALB ratio, a novel biomarker of systemic inflammation and nutritional status, may enhance sarcopenia prediction but remains underexplored in surgical oncology. This study aims to identify the predictors for preoperative sarcopenia prediction in gastric and colorectal cancer patients.

Methods

This retrospective study analyzed 145 patients undergoing curative surgery (2019–2021). Sarcopenia was defined by sex-specific CT-measured L3 skeletal muscle index (cutoffs, male ≤ 40.8 cm2/m2; female ≤ 34.9 cm2/m2). Multivariable logistic regression identified predictors, with model performance assessed via ROC analysis and Cohen’s Kappa.

Results

The cohort (median age 64 years; 73.8% male) comprised 66 gastric (45.5%) and 79 colorectal (54.5%) cancer patients, with 29 (20%) diagnosed with sarcopenia. Sarcopenic patients exhibited a higher NRS 2002 score (P < 0.001), lower PNI score (P < 0.05), and higher CRP/ALB ratio (P < 0.05). Multivariate logistic regression analysis results showed that CRP/ALB ratio (OR = 3.084, 95% CI 1.071–8.882, P = 0.037), age (OR = 1.074, 95% CI 1.021–1.130, P = 0.006), and BMI (OR = 0.667, 95% CI 0.542–0.820, P = 0.000) were associated with the increased risk of sarcopenia. The combined model achieved superior discrimination (AUC = 0.854, 95% CI 0.770–0.937), yielding 75.86% sensitivity and 84.82% specificity at optimal cutoff value − 1.0340, and a Cohen’s Kappa coefficient of 0.542 when compared to CT results.

Conclusion

The CRP/ALB ratio combined with BMI and age is utilized as a convenient and effective tool for preoperative sarcopenia screening. This model-driven approach provides robust strategies to facilitate preoperative interventions, optimize perioperative care, and enhance long-term oncological outcomes for patients undergoing gastric and colorectal cancer surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

No datasets were generated or analysed during the current study.

References

  1. Jardim SR, de Souza LM, de Souza HS. The rise of gastrointestinal cancers as a global phenomenon: unhealthy behavior or progress? Int J Environ Res Public Health. 2023;20(4):3640.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Baidoun F, Elshiwy K, Elkeraie Y, et al. Colorectal cancer epidemiology: recent trends and impact on outcomes[J]. Curr Drug Targets. 2021;22(9):998–1009.

    Article  CAS  PubMed  Google Scholar 

  3. Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer[J]. Lancet. 2019;394(10207):1467–80.

    Article  PubMed  Google Scholar 

  4. Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer[J]. Lancet. 2020;396(10251):635–48.

    Article  CAS  PubMed  Google Scholar 

  5. Ben-Aharon I, Van Laarhoven HWM, Fontana E, et al. Early-onset cancer in the gastrointestinal tract is on the rise-evidence and implications[J]. Cancer Discov. 2023;13(3):538–51.

    Article  CAS  PubMed  Google Scholar 

  6. Garla P, Waitzberg DL, Tesser A. Nutritional therapy in gastrointestinal cancers[J]. Gastroenterol Clin North Am. 2018;47(1):231–42.

    Article  PubMed  Google Scholar 

  7. Cho MR, Lee S, Song SK. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction[J]. J Korean Med Sci. 2022;37(18):e146.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing. 2019;48(1):16–31.

    Article  PubMed  Google Scholar 

  9. Zhang FM, Wu HF, Shi HP, et al. Sarcopenia and malignancies: epidemiology, clinical classification and implications[J]. Ageing Res Rev. 2023;91:102057.

    Article  PubMed  Google Scholar 

  10. Gibson DJ, Burden ST, Strauss BJ, et al. The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: a systematic review[J]. Eur J Clin Nutr. 2015;69(10):1079–86.

    Article  CAS  PubMed  Google Scholar 

  11. Zhuang CL, Huang DD, Pang WY, et al. Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort[J]. Medicine (Baltimore). 2016;95(13):e3164.

    Article  PubMed  Google Scholar 

  12. Xia L, Zhao R, Wan Q, et al. Sarcopenia and adverse health-related outcomes: an umbrella review of meta-analyses of observational studies[J]. Cancer Med. 2020;9(21):7964–78.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Simonsen C, De Heer P, Bjerre ED, et al. Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: a meta-analysis[J]. Ann Surg. 2018;268(1):58–69.

    Article  PubMed  Google Scholar 

  14. Prado CM, Baracos VE, Mccargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment[J]. Clin Cancer Res. 2009;15(8):2920–6.

    Article  CAS  PubMed  Google Scholar 

  15. Haiducu C, Buzea A, Mirea LE, Dan GA. The prevalence and the impact of sarcopenia in digestive cancers. A systematic review. Rom J Intern Med. 2021;59(4):328–44.

    PubMed  Google Scholar 

  16. Xie H, Wei L, Liu M, et al. Preoperative computed tomography-assessed sarcopenia as a predictor of complications and long-term prognosis in patients with colorectal cancer: a systematic review and meta-analysis[J]. Langenbecks Arch Surg. 2021;406(6):1775–88.

    Article  PubMed  Google Scholar 

  17. Fukuda Y, Yamamoto K, Hirao M, et al. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy[J]. Gastric Cancer. 2016;19(3):986–93.

    Article  PubMed  Google Scholar 

  18. Huang DD, Chen XX, Chen XY, et al. Sarcopenia predicts 1-year mortality in elderly patients undergoing curative gastrectomy for gastric cancer: a prospective study[J]. J Cancer Res Clin Oncol. 2016;142(11):2347–56.

    Article  CAS  PubMed  Google Scholar 

  19. Sun G, Li Y, Peng Y, et al. Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis[J]. Int J Colorectal Dis. 2018;33(10):1419–27.

    Article  PubMed  Google Scholar 

  20. Kudou K, Saeki H, Nakashima Y, et al. Prognostic significance of sarcopenia in patients with esophagogastric junction cancer or upper gastric cancer[J]. Ann Surg Oncol. 2017;24(7):1804–10.

    Article  PubMed  Google Scholar 

  21. Bossi P, Delrio P, Mascheroni A, Zanetti M. The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients. 2021;13(6):1980.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Avgerinos KI, Spyrou N, Mantzoros CS, et al. Obesity and cancer risk: emerging biological mechanisms and perspectives[J]. Metabolism. 2019;92:121–35.

    Article  CAS  PubMed  Google Scholar 

  23. Lin J, Zhang W, Huang Y, et al. Sarcopenia is associated with the neutrophil/lymphocyte and platelet/lymphocyte ratios in operable gastric cancer patients: a prospective study[J]. Cancer Manag Res. 2018;10:4935–44.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Gao B, Chen W, Liu Y, et al. Associations between nutrition risk scores and sarcopenia in gastrointestinal cancer patients: a cross-sectional study[J]. Support Care Cancer. 2022;30(4):3269–77.

    Article  PubMed  Google Scholar 

  25. Müller MJ, Braun W, Enderle J, et al. Beyond BMI: conceptual issues related to overweight and obese patients[J]. Obes Facts. 2016;9(3):193–205.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hong S, Zhou T, Fang W, et al. The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients[J]. Tumour Biol. 2015;36(5):3389–97.

    Article  CAS  PubMed  Google Scholar 

  27. Han Y, Wu J, Ji R, et al. Preoperative sarcopenia combined with prognostic nutritional index predicts long-term prognosis of radical gastrectomy with advanced gastric cancer: a comprehensive analysis of two-center study[J]. BMC Cancer. 2023;23(1):751.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Utsumi M, Inagaki M, Kitada K, Tokunaga N, Yonoki K, Sakurai Y, Okabayashi H, Hamano R, Miyasou H, Tsunemitsu Y, Otsuka S. Prognostic significance of sarcopenia and systemic inflammatory markers in biliary tract cancer: a retrospective cohort study. J Gastrointest Cancer. 2024;55(2):888–99.

    Article  CAS  PubMed  Google Scholar 

  29. Jiang N, Deng JY, Ding XW, et al. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer[J]. World J Gastroenterol. 2014;20(30):10537–44.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Peng H, Tan X. The prognostic significance of sarcopenia and the neutrophil-to-lymphocyte ratio in elderly patients with esophageal squamous cell carcinoma[J]. Cancer Manag Res. 2021;13:3209–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Lee SI, Choi CH, Park CH, et al. Nutritional indices for screening sarcopenia before adult cardiac surgery[J]. J Thorac Dis. 2023;15(6):3307–18.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Bullock AF, Greenley SL, McKenzie GA, Paton LW, Johnson MJ. Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis and meta-analysis. Eur J Clinic Nutrit. 2020;74(11):1519–35.

    Article  Google Scholar 

  33. Liao CK, Yu YL, Lin YC, et al. Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis[J]. World J Surg Oncol. 2021;19(1):139.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Toyokawa T, Muguruma K, Tamura T, et al. Comparison of the prognostic impact and combination of preoperative inflammation-based and/or nutritional markers in patients with stage II gastric cancer[J]. Oncotarget. 2018;9(50):29351–64.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Yang X, Song X, Zhang L, et al. Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer: a systematic review and meta-analysis[J]. Medicine (Baltimore). 2020;99(10):e19362.

    Article  PubMed  Google Scholar 

  36. Christodoulidis G, Voutyras A, Fotakopoulos G, et al. CRP to albumin ratio as a prognostic nutrition-based biomarker for patients with gastric cancer: a narrative review[J]. Cureus. 2024;16(10):e71516.

    PubMed  PubMed Central  Google Scholar 

  37. Matsunaga T, Miyata H, Sugimura K, et al. Prognostic significance of sarcopenia and systemic inflammatory response in patients with esophageal cancer[J]. Anticancer Res. 2019;39(1):449–58.

    Article  CAS  PubMed  Google Scholar 

  38. Miyoshi K, Shimoda M, Udo R, et al. Urinary titin N-terminal fragment concentration is an indicator of preoperative sarcopenia and nutritional status in patients with gastrointestinal tract and hepatobiliary pancreatic malignancies[J]. Nutrition. 2020;79–80:110957.

    Article  PubMed  Google Scholar 

  39. Kurk S, Peeters P, Stellato R, et al. Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients[J]. J Cachexia Sarcopenia Muscle. 2019;10(4):803–13.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Uchida T, Sekine R, Matsuo K, et al. Benefit of laparoscopic compared to standard open gastric cancer surgery for sarcopenic patients: a propensity score-matching analysis[J]. Surg Endosc. 2022;36(12):9244–53.

    Article  PubMed  Google Scholar 

  41. Pędziwiatr M, Pisarska M, Major P, et al. Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes[J]. Eur J Surg Oncol. 2016;42(6):779–87.

    Article  PubMed  Google Scholar 

  42. Yamamoto K, Nagatsuma Y, Fukuda Y, et al. Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer[J]. Gastric Cancer. 2017;20(5):913–8.

    Article  PubMed  Google Scholar 

  43. Nilsson MI, Mikhail A, Lan L, Di Carlo A, Hamilton B, Barnard K, Hettinga BP, Hatcher E, Tarnopolsky MG, Nederveen JP, Bujak AL. A five-ingredient nutritional supplement and home-based resistance exercise improve lean mass and strength in free-living elderly. Nutrients. 2020;12(8):2391.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Jiang Y, Xu B, Zhang K, et al. The association of lipid metabolism and sarcopenia among older patients: a cross-sectional study[J]. Sci Rep. 2023;13(1):17538.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Zhang Y, Zhang L, Guan Y, et al. Establishment and validation of a risk prediction model for sarcopenia in gastrointestinal cancer patients: a systematic review and meta-analysis-based approach[J]. Clin Nutr. 2024;43(11):91–8.

    Article  PubMed  Google Scholar 

Download references

Funding

The research was funded by the Nursing Research Fund of Jiangbei Campus, Nanjing Drum Tower Hospital (2023-B1611).

Author information

Authors and Affiliations

Authors

Contributions

Beijia Zhou contributed to the research design, data analysis and final writing; Tingting Tao and Yanjun Song contributed to the data collection and data analysis. Chen Chen and Xiaotian Chen was responsible for the manuscript revision. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Tingting Tao.

Ethics declarations

Ethics Approval

The study was approved by the Clinical Research Ethics Committee of Nanjing Drum Tower Hospital (2024–354-02).

Consent to Participate

Written consent was obtained from all participants.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, B., Song, Y., Chen, C. et al. Preoperative Prediction of Sarcopenia in Patients Scheduled for Gastric and Colorectal Cancer Surgery. J Gastrointest Canc 56, 82 (2025). https://doi.org/10.1007/s12029-025-01206-y

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12029-025-01206-y

Keywords